Ascending Single-Dose and Multiple-Dose Study to Evaluate HSK31679 in Healthy Subjects and Subjects With Elevated LDL-C
Clinical trial NCT05531097 · COMPLETED
Trial details
- NCT number
- NCT05531097
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-22
- Primary completion
- 2022-09-21
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.